Skip to main content

Assessing the Feasibility of a Custom Psychedelic-assisted Group Program on Mental and Physical Health in First Responders

This study is a two-group feasibility study of oral psilocybin combined with a 12-week group-based program, customized for firefighters. Trained facilitators will help create a trauma-informed space for the group (n = 6-8) to thrive and promote cognitive resilience. The topics covered throughout the 12 weeks include breath-work, mindfulness, self-compassion, embodiment, and Internal Family Systems work. Group 1 (control): 12-week group-based program, with a breathwork day at week 10 Group 2 (intervention): 12-week group-based program, with a 10mg dose of psilocybin (PEX010) at Week 10 Assessment timepoints: * Baseline * Mid-program (Week 6) * End of program (Week 12) * 6-month follow up

Status
unknown
Phase
Phase 1, Phase 2
Institution
Empower Research Inc
Principal investigator
Reginald Peters, MD
Start date
2025-01-01
End date
2025-09-01
Registry ID
NCT06471959

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.